CompoAtlas

Nova-X

On sale on the US market (according to the DSLD)

Gaspari Nutrition, food supplement from the US market

Nova-X (Gaspari Nutrition), a food supplement au code-barres 646511022829, is described by its US market label. If sold in France, it would be subject to 2 points of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.

Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.

Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.

If this product were sold in France

A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.

Label composition

Brand
Gaspari Nutrition
Barcode
646511022829
Form
Tablet
One serving
1 tablet
Servings
up to 2 servings per day
Other ingredients (in English, as written)
LipoAbsorb Matrix:, Alcohol, Glyceryl Stearate, Oleic Acid, Linoleic Acid, Linolenic Acid, Ascorbyl Palmitate, Microcrystalline Cellulose, Carboxymethylstarch Sodium Salt, Silica, Colloidal Anhydrous, Magnesium Stearate, Enteric Coating, FD&C Blue #1, FD&C Red #40
Ingredient (as written, in English)CategoryPer serving
AndrosteroneHormone50 mg
Mucuna pruriens extract (Mucuna pruriens)Plant250 mg
Toxicodendron vernicifluum extractPlant100 mg
Diosterol brand Dioscorea nipponica makino 50-67:1 extractPlant200 mg
Progenin IIIOther substancenot stated
ProtodioscinOther substancenot stated
Iridoid GlycosidesOther substancenot stated
DiosgeninOther substancenot stated
5a-Hydroxy LaxogeninOther substancenot stated
DHT Inhibiting ComplexBlend210 mg
Pygeum africanum bark extract (Prunus africana)Plantnot stated
13% total SterolsFat6.5 mg
Saw Palmetto Liposterolic berry extract (Serenoa repens)Plantnot stated
N-Methyl-D-Aspartic AcidOther substance30 mg

Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.

Other versions of this label

The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.

This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Pygeum africanum bark extract
    Read the warning, when it applies and the studies cited

    PYGEUM - PRUNUS AFRICANA

    Route of administration: Oral

    Cautions and warnings

    Condition of application: Standardized extracts making a claim for symptoms of benign prostatic hyperplasia (adult males).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to exclude a diagnosis of prostate cancer (Goldman and Ausiello 2004).

    Sources cited by Health Canada (1)
    • Goldman L, Ausiello D. Cecil Textbook of Medicine. 22nd edition. Philadelphia (PA): Saunders; 2004.

    Condition of application: Non-standardized preparations for adults (i.e., including women) (safety only).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Health Canada monograph dated 26 June 2026

  • Saw Palmetto Liposterolic berry extract
    Read the warning, when it applies and the studies cited

    SAW PALMETTO – SERENOA REPENS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All subpopulations.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: Adult males only.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to exclude a diagnosis of prostate cancer (USP-NF 2024; Mills and Bone 2005).

    Sources cited by Health Canada (2)
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
    • USP-NF 2024: United States Pharmacopeia and the National Formulary. Rockville (MD): The United States Pharmacopeial Convention, Inc.; 2024.

    Condition of application: Adult females only.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking oral contraceptives or hormone replacement therapy (UpToDate 2024).

    Sources cited by Health Canada (1)
    • UpToDate 2024. UpToDate database. Clinical use of Saw palmetto. [Consulted 2024 December 5]. Available from : https://www.uptodate.com/contents/clinical-use-of-saw-palmetto?search=saw%20palmetto&source=search_result&selectedTitle=1%7E9&usage_type=default&display_rank=1

    Contraindications

    Condition of application: Adult females only.

    Do not use if you are pregnant, breastfeeding, or attempting to conceive (UpToDate 2024).

    Sources cited by Health Canada (1)
    • UpToDate 2024. UpToDate database. Clinical use of Saw palmetto. [Consulted 2024 December 5]. Available from : https://www.uptodate.com/contents/clinical-use-of-saw-palmetto?search=saw%20palmetto&source=search_result&selectedTitle=1%7E9&usage_type=default&display_rank=1

    Health Canada monograph dated 19 December 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).

Photograph the packaging

Brand : Gaspari Nutrition

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Nova-X (Gaspari Nutrition): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/646511022829-nova-x-gaspari-nutrition, updated 22 December 2017.

List recorded in 2017. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line